首页--医药、卫生论文--肿瘤学论文--造血器及淋巴系肿瘤论文

MBD2as a Potential Target for Treatment of Hematopoietic Malignancies

LIST OF ABBREVIATIONS USED第8-9页
ABSTRACT第9-10页
LIST OF TABLES第15-16页
LIST OF FIGURES第16-18页
1. Introduction第18-19页
2. Statement of the Problem第19-20页
3. Research Questions第20页
4. Objectives第20-21页
5. Jusntification第21-22页
6. Part Ⅰ:detecting MBD2 protein and mRNA第22-31页
    6.1 Materials第22-24页
    6.2 Methods第24-28页
        6.2.1 Cell cultures第24页
        6.2.2 Protein preparation (Extraction)第24-25页
        6.2.3 Western blotting第25-26页
        6.2.4 Real-Time PCR第26-28页
    6.3 Results第28-30页
        6.3.1 Expression MBD2 protein by several hematopoietic cell lines using western blotting第28-29页
        6.3.2 Expression of MBD2-mRNA by using real-time PCR第29-30页
    6.4 Discussion第30-31页
7. Part Ⅱ:MBD2-Knockdown, Cell cycle, Apoptosis, and Colony Forming Cell Assay第31-75页
    7.1 Materials第31-34页
    7.2 Methods第34-40页
        7.2.1 Lentivirus shRNA-MBD2 analysis and Checking第34页
        7.2.2 MBD2 knocking down第34-35页
        7.2.3 Western blot to detect MBD2 knocking down第35-37页
        7.2.4 SYBR Green fluorescence based quantitative real-time PCR to detect MBD2 knocking down第37-38页
        7.2.5 Cell cycle Analysis of shRNA-MBD2-Knocked down Cells第38-39页
        7.2.6 Apoptosis analyses of shRNA-MBD2-Knocked down Cells第39页
        7.2.7 Colony forming assay of sh-RNA-MBD2 knocked down cells第39-40页
    7.3 Results第40-72页
        7.3.1 Result of Lentivirus shRNA-MBD2 analysis and Checking第40-43页
        7.3.2 Result of Western blotting to detect MBD2 knocking down第43-45页
        7.3.3 Result of SYBR Green fluorescence based quantitative real-time PCR to detect MBD2 knocking down第45-47页
        7.3.4 Result of Cell cycle Analysis of shRNA-MBD2-Knocked down Cells第47-58页
        7.3.5 Result of apoptosis analyses of Lentivirus shRNA-MBD2-Knocked Down Cells Lines第58-68页
        7.3.6 Results of Colony Forming cell Assay第68-72页
    7.4 Discussion第72-75页
8 Part Ⅲ:MBD2 Protein Role in Increasing response of Hematopoietic Malignancies to Treatment第75-83页
    8.1 Apoptosis Analysis of Treated THP-1Cell Line with DNR Treatment第75-76页
    8.2 Cell Cycle Analysis of Treated Cell Line THP-1 with DNR第76-77页
    8.3 Results of apoptosis analysis of treated THP-1 with DAR第77页
    8.4 Results of Cell Cycle analysis of treated THP-1 with DAR第77-82页
    8.5 Discussion of Part Ⅲ第82-83页
9 Review:Myelodysplastic syndrome (MDS)第83-84页
10 Pathogenesis of Myelodysplastic Syndrome (MDS)第84-86页
11 Genetic Alterations in Signal Transduction and Cell Surface Receptors第86页
12 Alterations of Transcription Factors and Cell Cycle Regulators第86-89页
13 Spliceosome Mutations in Myelodysplastic Syndrome (MDS)第89-91页
14 Epigenetic Alterations in MDS第91-95页
15 Cytogenetic Abnormalities in MDS第95-97页
16 Classification and Prognostic Scoring Systems of MDS第97-100页
17 Natural History and Goals of Treatment of MDS第100-101页
18 Treatment of MDS第101页
19 Hematopoietic Cell Transplantation (HCT) of MDS第101-102页
20 Epigenetic Treatment Strategy of MDS第102-103页
21 DNA Demethy lating Agents第103-104页
22 Histone Deacetylase Inhibitors第104页
23 Combination Strategies第104-106页
24 Epigenetic第106-107页
25 Modification of Histone and Chromatin Function第107-108页
26 DNA Methylation第108-109页
27 Methylation Enzymes第109-110页
28 Methylation in Human Development第110-112页
29 Methylation and Cancer第112-113页
30 Role of Methylation Therapy in Treatment第113页
31 The Mixed Lineage Leukemia (MLL) rearrangements第113-114页
32 MLL Protein Structure第114-117页
33 MLL in Normal Hematopoiesis第117页
34 Disordered Epigenetic Regulation in MLL Fusions第117-118页
35 Target Genes第118-120页
36 Disordered Epigenetic Regulation in MLL-Partial Tandem Duplication (MLL-PTD)第120-121页
37 Methyl-Binding Domain Proteins and its Role in Tumorigenesis第121-123页
38 MBD Family Structure第123-124页
39 Literature review第124-138页
40 References第138-148页
ACKNOWLEDGMENT第148-149页

论文共149页,点击 下载论文
上一篇:影响和预测库欣病患者术后缓解的相关因素分析
下一篇:p21激活激酶1的激活肽段对血管紧张素Ⅱ所诱导的心肌肥厚与心律失常的抑制与改善作用